Medical Care

Global Cell-Based Immunotherapy Market Research Report 2025

The global market for Cell-Based Immunotherapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cell-Based Immunotherapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell-Based Immunotherapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell-Based Immunotherapy in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell-Based Immunotherapy include Novartis, Gilead Sciences, AbbVie, Bristol-Myers Squibb, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Eli Lilly and Company, GSK, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell-Based Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-Based Immunotherapy.
The Cell-Based Immunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell-Based Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell-Based Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Gilead Sciences
AbbVie
Bristol-Myers Squibb
Amgen
AstraZeneca
Biogen
Boehringer Ingelheim
Eli Lilly and Company
GSK
Pfizer
Roche
Takara Bio
Bausch Health
Apac Biotech
Dendreon Pharmaceuticals (SanPower)
JW CreaGene
Green Cross Corp
Segment by Type
Autologous Cellular Immunotherapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy
Dendritic Cell-based Vaccine Therapy
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-Based Immunotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Based Immunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Autologous Cellular Immunotherapy
1.2.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy
1.2.4 Dendritic Cell-based Vaccine Therapy
1.3 Market by Application
1.3.1 Global Cell-Based Immunotherapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-Based Immunotherapy Market Perspective (2020-2031)
2.2 Global Cell-Based Immunotherapy Growth Trends by Region
2.2.1 Global Cell-Based Immunotherapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell-Based Immunotherapy Historic Market Size by Region (2020-2025)
2.2.3 Cell-Based Immunotherapy Forecasted Market Size by Region (2026-2031)
2.3 Cell-Based Immunotherapy Market Dynamics
2.3.1 Cell-Based Immunotherapy Industry Trends
2.3.2 Cell-Based Immunotherapy Market Drivers
2.3.3 Cell-Based Immunotherapy Market Challenges
2.3.4 Cell-Based Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-Based Immunotherapy Players by Revenue
3.1.1 Global Top Cell-Based Immunotherapy Players by Revenue (2020-2025)
3.1.2 Global Cell-Based Immunotherapy Revenue Market Share by Players (2020-2025)
3.2 Global Cell-Based Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell-Based Immunotherapy Revenue
3.4 Global Cell-Based Immunotherapy Market Concentration Ratio
3.4.1 Global Cell-Based Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Based Immunotherapy Revenue in 2024
3.5 Global Key Players of Cell-Based Immunotherapy Head office and Area Served
3.6 Global Key Players of Cell-Based Immunotherapy, Product and Application
3.7 Global Key Players of Cell-Based Immunotherapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Based Immunotherapy Breakdown Data by Type
4.1 Global Cell-Based Immunotherapy Historic Market Size by Type (2020-2025)
4.2 Global Cell-Based Immunotherapy Forecasted Market Size by Type (2026-2031)
5 Cell-Based Immunotherapy Breakdown Data by Application
5.1 Global Cell-Based Immunotherapy Historic Market Size by Application (2020-2025)
5.2 Global Cell-Based Immunotherapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell-Based Immunotherapy Market Size (2020-2031)
6.2 North America Cell-Based Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell-Based Immunotherapy Market Size by Country (2020-2025)
6.4 North America Cell-Based Immunotherapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-Based Immunotherapy Market Size (2020-2031)
7.2 Europe Cell-Based Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell-Based Immunotherapy Market Size by Country (2020-2025)
7.4 Europe Cell-Based Immunotherapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-Based Immunotherapy Market Size (2020-2031)
8.2 Asia-Pacific Cell-Based Immunotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell-Based Immunotherapy Market Size (2020-2031)
9.2 Latin America Cell-Based Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell-Based Immunotherapy Market Size by Country (2020-2025)
9.4 Latin America Cell-Based Immunotherapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-Based Immunotherapy Market Size (2020-2031)
10.2 Middle East & Africa Cell-Based Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Cell-Based Immunotherapy Introduction
11.1.4 Novartis Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Cell-Based Immunotherapy Introduction
11.2.4 Gilead Sciences Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.2.5 Gilead Sciences Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Cell-Based Immunotherapy Introduction
11.3.4 AbbVie Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.3.5 AbbVie Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Cell-Based Immunotherapy Introduction
11.4.4 Bristol-Myers Squibb Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Cell-Based Immunotherapy Introduction
11.5.4 Amgen Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.5.5 Amgen Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Cell-Based Immunotherapy Introduction
11.6.4 AstraZeneca Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Biogen
11.7.1 Biogen Company Details
11.7.2 Biogen Business Overview
11.7.3 Biogen Cell-Based Immunotherapy Introduction
11.7.4 Biogen Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.7.5 Biogen Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Cell-Based Immunotherapy Introduction
11.8.4 Boehringer Ingelheim Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Details
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Cell-Based Immunotherapy Introduction
11.9.4 Eli Lilly and Company Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.9.5 Eli Lilly and Company Recent Development
11.10 GSK
11.10.1 GSK Company Details
11.10.2 GSK Business Overview
11.10.3 GSK Cell-Based Immunotherapy Introduction
11.10.4 GSK Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.10.5 GSK Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Cell-Based Immunotherapy Introduction
11.11.4 Pfizer Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.11.5 Pfizer Recent Development
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Cell-Based Immunotherapy Introduction
11.12.4 Roche Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.12.5 Roche Recent Development
11.13 Takara Bio
11.13.1 Takara Bio Company Details
11.13.2 Takara Bio Business Overview
11.13.3 Takara Bio Cell-Based Immunotherapy Introduction
11.13.4 Takara Bio Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.13.5 Takara Bio Recent Development
11.14 Bausch Health
11.14.1 Bausch Health Company Details
11.14.2 Bausch Health Business Overview
11.14.3 Bausch Health Cell-Based Immunotherapy Introduction
11.14.4 Bausch Health Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.14.5 Bausch Health Recent Development
11.15 Apac Biotech
11.15.1 Apac Biotech Company Details
11.15.2 Apac Biotech Business Overview
11.15.3 Apac Biotech Cell-Based Immunotherapy Introduction
11.15.4 Apac Biotech Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.15.5 Apac Biotech Recent Development
11.16 Dendreon Pharmaceuticals (SanPower)
11.16.1 Dendreon Pharmaceuticals (SanPower) Company Details
11.16.2 Dendreon Pharmaceuticals (SanPower) Business Overview
11.16.3 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Introduction
11.16.4 Dendreon Pharmaceuticals (SanPower) Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.16.5 Dendreon Pharmaceuticals (SanPower) Recent Development
11.17 JW CreaGene
11.17.1 JW CreaGene Company Details
11.17.2 JW CreaGene Business Overview
11.17.3 JW CreaGene Cell-Based Immunotherapy Introduction
11.17.4 JW CreaGene Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.17.5 JW CreaGene Recent Development
11.18 Green Cross Corp
11.18.1 Green Cross Corp Company Details
11.18.2 Green Cross Corp Business Overview
11.18.3 Green Cross Corp Cell-Based Immunotherapy Introduction
11.18.4 Green Cross Corp Revenue in Cell-Based Immunotherapy Business (2020-2025)
11.18.5 Green Cross Corp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cell-Based Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Autologous Cellular Immunotherapy
Table 3. Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Table 4. Key Players of Dendritic Cell-based Vaccine Therapy
Table 5. Global Cell-Based Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cell-Based Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Cell-Based Immunotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Cell-Based Immunotherapy Market Share by Region (2020-2025)
Table 9. Global Cell-Based Immunotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Cell-Based Immunotherapy Market Share by Region (2026-2031)
Table 11. Cell-Based Immunotherapy Market Trends
Table 12. Cell-Based Immunotherapy Market Drivers
Table 13. Cell-Based Immunotherapy Market Challenges
Table 14. Cell-Based Immunotherapy Market Restraints
Table 15. Global Cell-Based Immunotherapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Cell-Based Immunotherapy Market Share by Players (2020-2025)
Table 17. Global Top Cell-Based Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Immunotherapy as of 2024)
Table 18. Ranking of Global Top Cell-Based Immunotherapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Cell-Based Immunotherapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Cell-Based Immunotherapy, Headquarters and Area Served
Table 21. Global Key Players of Cell-Based Immunotherapy, Product and Application
Table 22. Global Key Players of Cell-Based Immunotherapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell-Based Immunotherapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Cell-Based Immunotherapy Revenue Market Share by Type (2020-2025)
Table 26. Global Cell-Based Immunotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Cell-Based Immunotherapy Revenue Market Share by Type (2026-2031)
Table 28. Global Cell-Based Immunotherapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Cell-Based Immunotherapy Revenue Market Share by Application (2020-2025)
Table 30. Global Cell-Based Immunotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Cell-Based Immunotherapy Revenue Market Share by Application (2026-2031)
Table 32. North America Cell-Based Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Cell-Based Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Cell-Based Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Cell-Based Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Cell-Based Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Cell-Based Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Cell-Based Immunotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Cell-Based Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Cell-Based Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Cell-Based Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Cell-Based Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Novartis Company Details
Table 48. Novartis Business Overview
Table 49. Novartis Cell-Based Immunotherapy Product
Table 50. Novartis Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 51. Novartis Recent Development
Table 52. Gilead Sciences Company Details
Table 53. Gilead Sciences Business Overview
Table 54. Gilead Sciences Cell-Based Immunotherapy Product
Table 55. Gilead Sciences Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 56. Gilead Sciences Recent Development
Table 57. AbbVie Company Details
Table 58. AbbVie Business Overview
Table 59. AbbVie Cell-Based Immunotherapy Product
Table 60. AbbVie Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 61. AbbVie Recent Development
Table 62. Bristol-Myers Squibb Company Details
Table 63. Bristol-Myers Squibb Business Overview
Table 64. Bristol-Myers Squibb Cell-Based Immunotherapy Product
Table 65. Bristol-Myers Squibb Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 66. Bristol-Myers Squibb Recent Development
Table 67. Amgen Company Details
Table 68. Amgen Business Overview
Table 69. Amgen Cell-Based Immunotherapy Product
Table 70. Amgen Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 71. Amgen Recent Development
Table 72. AstraZeneca Company Details
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Cell-Based Immunotherapy Product
Table 75. AstraZeneca Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. Biogen Company Details
Table 78. Biogen Business Overview
Table 79. Biogen Cell-Based Immunotherapy Product
Table 80. Biogen Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 81. Biogen Recent Development
Table 82. Boehringer Ingelheim Company Details
Table 83. Boehringer Ingelheim Business Overview
Table 84. Boehringer Ingelheim Cell-Based Immunotherapy Product
Table 85. Boehringer Ingelheim Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 86. Boehringer Ingelheim Recent Development
Table 87. Eli Lilly and Company Company Details
Table 88. Eli Lilly and Company Business Overview
Table 89. Eli Lilly and Company Cell-Based Immunotherapy Product
Table 90. Eli Lilly and Company Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 91. Eli Lilly and Company Recent Development
Table 92. GSK Company Details
Table 93. GSK Business Overview
Table 94. GSK Cell-Based Immunotherapy Product
Table 95. GSK Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 96. GSK Recent Development
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer Cell-Based Immunotherapy Product
Table 100. Pfizer Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 101. Pfizer Recent Development
Table 102. Roche Company Details
Table 103. Roche Business Overview
Table 104. Roche Cell-Based Immunotherapy Product
Table 105. Roche Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 106. Roche Recent Development
Table 107. Takara Bio Company Details
Table 108. Takara Bio Business Overview
Table 109. Takara Bio Cell-Based Immunotherapy Product
Table 110. Takara Bio Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 111. Takara Bio Recent Development
Table 112. Bausch Health Company Details
Table 113. Bausch Health Business Overview
Table 114. Bausch Health Cell-Based Immunotherapy Product
Table 115. Bausch Health Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 116. Bausch Health Recent Development
Table 117. Apac Biotech Company Details
Table 118. Apac Biotech Business Overview
Table 119. Apac Biotech Cell-Based Immunotherapy Product
Table 120. Apac Biotech Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 121. Apac Biotech Recent Development
Table 122. Dendreon Pharmaceuticals (SanPower) Company Details
Table 123. Dendreon Pharmaceuticals (SanPower) Business Overview
Table 124. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product
Table 125. Dendreon Pharmaceuticals (SanPower) Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 126. Dendreon Pharmaceuticals (SanPower) Recent Development
Table 127. JW CreaGene Company Details
Table 128. JW CreaGene Business Overview
Table 129. JW CreaGene Cell-Based Immunotherapy Product
Table 130. JW CreaGene Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 131. JW CreaGene Recent Development
Table 132. Green Cross Corp Company Details
Table 133. Green Cross Corp Business Overview
Table 134. Green Cross Corp Cell-Based Immunotherapy Product
Table 135. Green Cross Corp Revenue in Cell-Based Immunotherapy Business (2020-2025) & (US$ Million)
Table 136. Green Cross Corp Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
Table 140. Authors List of This Report


List of Figures
Figure 1. Cell-Based Immunotherapy Picture
Figure 2. Global Cell-Based Immunotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cell-Based Immunotherapy Market Share by Type: 2024 VS 2031
Figure 4. Autologous Cellular Immunotherapy Features
Figure 5. Chimeric Antigen Receptor (CAR) T-Cell Therapy Features
Figure 6. Dendritic Cell-based Vaccine Therapy Features
Figure 7. Global Cell-Based Immunotherapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Cell-Based Immunotherapy Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Cell-Based Immunotherapy Report Years Considered
Figure 14. Global Cell-Based Immunotherapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Cell-Based Immunotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Cell-Based Immunotherapy Market Share by Region: 2024 VS 2031
Figure 17. Global Cell-Based Immunotherapy Market Share by Players in 2024
Figure 18. Global Top Cell-Based Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Immunotherapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Cell-Based Immunotherapy Revenue in 2024
Figure 20. North America Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Cell-Based Immunotherapy Market Share by Country (2020-2031)
Figure 22. United States Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cell-Based Immunotherapy Market Share by Country (2020-2031)
Figure 26. Germany Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cell-Based Immunotherapy Market Share by Region (2020-2031)
Figure 34. China Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cell-Based Immunotherapy Market Share by Country (2020-2031)
Figure 42. Mexico Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cell-Based Immunotherapy Market Share by Country (2020-2031)
Figure 46. Turkey Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Cell-Based Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Novartis Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 50. Gilead Sciences Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 51. AbbVie Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 53. Amgen Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 54. AstraZeneca Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 55. Biogen Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 56. Boehringer Ingelheim Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 57. Eli Lilly and Company Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 58. GSK Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 59. Pfizer Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 60. Roche Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 61. Takara Bio Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 62. Bausch Health Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 63. Apac Biotech Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 64. Dendreon Pharmaceuticals (SanPower) Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 65. JW CreaGene Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 66. Green Cross Corp Revenue Growth Rate in Cell-Based Immunotherapy Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies